IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.

Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...

Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.

A study led by UMass Chan Medical School researchers has demonstrated that a gene therapy to correct a mutation that causes ...

A new study led by Profs. Fan Kelong and Yan Xiyun from the Institute of Biophysics of the Chinese Academy of Sciences ...